News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,927 Results
Type
Article (160)
Company Profile (1)
Press Release (1766)
Section
Business (703)
Career Advice (1)
Deals (108)
Drug Development (322)
Employer Resources (4)
FDA (64)
Job Trends (40)
News (1200)
Policy (109)
Tag
Academia (2)
Adcomms (1)
Alliances (162)
Alzheimer's disease (1)
Antibody-drug conjugate (ADC) (12)
Approvals (68)
Artificial intelligence (3)
Bankruptcy (1)
Best Places to Work (23)
Biotechnology (1)
Brain cancer (1)
Cancer (24)
Career advice (1)
Clinical research (318)
Collaboration (8)
C-suite (8)
Data (32)
Diagnostics (5)
Diversity, equity & inclusion (1)
Drug discovery (1)
Earnings (282)
Employer branding (1)
Employer resources (3)
Events (202)
Executive appointments (10)
FDA (78)
Fibrodysplasia Ossificans Progressiva (1)
Funding (2)
GLP-1 (3)
Government (8)
Guidances (6)
Healthcare (25)
Immunology and inflammation (1)
Immuno-oncology (1)
Indications (1)
Infectious disease (1)
IPO (47)
Job creations (18)
Job search strategy (1)
Kidney cancer (1)
Layoffs (7)
Legal (6)
Lymphoma (3)
Management (1)
MASH (2)
Medical device (1)
Medtech (1)
Mergers & acquisitions (67)
Metabolic disorders (3)
Neurodegenerative disease (1)
Neuroscience (4)
NextGen: Class of 2026 (9)
Non-profit (7)
Obesity (1)
Opinion (1)
Pancreatic cancer (3)
People (290)
Phase 1 (58)
Phase 2 (100)
Phase 3 (183)
Pipeline (41)
Policy (1)
Postmarket research (3)
Preclinical (12)
Prostate cancer (2)
Psychedelics (1)
Rare diseases (7)
Real estate (14)
Recruiting (1)
Regulatory (113)
Research institute (2)
RSV (1)
Series A (2)
Startups (15)
The Weekly (1)
Date
Today (1)
Last 7 days (2)
Last 30 days (14)
Last 365 days (112)
2026 (31)
2025 (109)
2024 (115)
2023 (146)
2022 (198)
2021 (164)
2020 (146)
2019 (126)
2018 (103)
2017 (107)
2016 (79)
2015 (79)
2014 (74)
2013 (50)
2012 (62)
2011 (65)
2010 (69)
Location
Africa (2)
Asia (59)
Australia (3)
California (36)
Canada (8)
China (5)
Europe (953)
Florida (1)
Illinois (5)
Japan (1)
Maryland (2)
Massachusetts (47)
New Jersey (3)
New York (4)
Northern California (27)
Pennsylvania (1)
South America (3)
Southern California (3)
Texas (2)
United States (102)
Wisconsin (1)
1,927 Results for "ipsen".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cancer
Ipsen Pulls Cancer Drug Amid Risk of Secondary Malignancies
Ipsen will withdraw Tazverik’s follicular lymphoma and epithelioid sarcoma indications as emerging data point to an elevated safety risk in patients undergoing treatment.
March 9, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Ipsen showcases transformative potential of early immuno-oncology pipeline at AACR
March 18, 2026
·
7 min read
Press Releases
Ipsen appoints Michelle C. Werner as EVP, President of North America
March 12, 2026
·
7 min read
Press Releases
Ipsen voluntarily withdraws Tazverik® (tazemetostat) in follicular lymphoma and epithelioid sarcoma
March 9, 2026
·
8 min read
Press Releases
Update: Ipsen voluntarily withdraws Tazverik® (tazemetostat) in follicular lymphoma and epithelioid sarcoma
March 9, 2026
·
8 min read
Press Releases
New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS
January 14, 2026
·
10 min read
Press Releases
Ipsen nominates Peter Guenter to its Board of Directors
January 29, 2026
·
6 min read
Press Releases
GENFIT to receive US$20M milestone after Ipsen’s Iqirvo® exceeds the US$200M threshold in its first full year of net sales
February 12, 2026
·
8 min read
Press Releases
U.S. FDA grants Ipsen’s IPN60340 (ICT01) Breakthrough Therapy Designation in first line unfit Acute Myeloid Leukemia
January 14, 2026
·
8 min read
Press Releases
Ipsen – Half year statement – 2025 12 31
January 7, 2026
·
5 min read
1 of 193
Next
